GLP-1 Black Friday Deals 2026: What's Real, What's Not, and Whether Waiting Costs You

By Weight Loss Provider Guide · Independent comparison resource for GLP-1 telehealth providers
Last verified: August 12, 2026 · Next scheduled check: September 1, 2026

Some links on this page are affiliate links. If you use one, we may earn a commission. It does not change your price. It did not change any number, warning, or verdict below.

Black Friday 2026 is Friday, November 27. Cyber Monday is Monday, November 30.

Here is the short answer on GLP-1 Black Friday deals: no 2026 seasonal GLP-1 offer is confirmed yet, and last year's prices do not support one easy promise. Some 2025 deal prices are still matched on current provider pages. At least one was slightly lower than the same provider's current bundle. Some are now beaten elsewhere. Some current pages conflict so badly that no honest winner can be named.

One date is real right now. The limited $149 self-pay offer for eligible Wegovy® 4 mg tablet fills ends August 31, 2026. The standard self-pay price after that is $199. That happens 88 days before Black Friday.

At the same time, the current $199 introductory price for the first two eligible fills of the two lowest Wegovy pen doses runs through December 31, 2026. It is already live, and it is scheduled to remain live through Black Friday.

The verdict: do not let an unannounced sale decide when you start a prescription medicine. First decide which lane you are in:

1. FDA-approved brand-name medicine or compounded medicine
2. Insurance or self-pay
3. Pill or shot
4. What you must pay today, not just the advertised monthly rate
5. What the second charge will be

Those five facts matter more than the date on the calendar.

There is one more thing we found that flips this whole search on its head. Two 2025 deal roundups gave prices for the same providers on the same holiday weekend that were as much as 4.5 times apart. First, the receipts.

The receipt table: last year's Black Friday prices vs. today

We went back to two published 2025 GLP-1 Black Friday roundups, pulled six headline prices, and checked the same provider's public pricing when we could. We also checked today's market against official manufacturer and provider pages.

That last part matters. A 2025 price from Provider A cannot prove that Provider B is cheaper today. This table keeps the same-provider test separate from the current-market test.

What this table really proves

It does not prove that most 2025 deals were bad.

It proves something more useful:

• At least one old holiday bundle was lower than the same provider's current public bundle, while another headline rate is matched today.
• Another provider may now list a lower number without calling it Black Friday.
• A low “per month” number can hide a three-, six-, or twelve-month payment due today.
• Several providers publish prices that conflict with their own other pages or even with the same page.
• A deal roundup is not a substitute for the provider's live checkout and terms.

Read this twice: the word deal is not the comparison. The comparison is same medicine lane, same dose, same term, same cash due today, same renewal price, and same date checked.

Three strong prices today were not Black Friday deals

These are manufacturer programs, not holiday offers:

Two of those oral options did not exist in their current form last Black Friday. Foundayo was FDA-approved on April 1, 2026.

Price rule for this whole page: “manufacturer-confirmed” means we found the number on the drug maker's current program page. “Provider-stated” means the provider publishes it, but we did not complete a prescription or guarantee the checkout result. “Historical roundup only” means the old price came from a 2025 article, not a live provider page.

When is Black Friday 2026, and do GLP-1 prices actually drop?

Black Friday 2026 is Friday, November 27. Cyber Monday is Monday, November 30.

GLP-1 prices can move around that weekend. In the 2025 evidence we checked, the seasonal coupon activity was in compounded telehealth programs. Neither roundup listed a Black Friday sale for an FDA-approved brand-name drug, and we found no 2025 manufacturer Black Friday offer.

That last sentence is the part most people do not expect.

If you want Wegovy, Zepbound, Foundayo, Ozempic, or Mounjaro, there is no announced 2026 manufacturer Black Friday sale today. Novo Nordisk and Eli Lilly can still change their programs. They have done that before. But there is no verified reason on August 12 to assume November 27 will beat the programs already live.

A quick lane check:

FDA-approved brand-name medicine was reviewed by FDA for its approved use, manufacturing, labeling, safety, and effectiveness.

Compounded medicine is prepared for a patient under federal and state compounding rules. Compounded drugs are not FDA-approved. FDA does not review each compounded drug for safety, effectiveness, or quality before it is sold. A compounded product is not an FDA-approved generic version of Wegovy or Zepbound.

Hold those two lanes in your head. They have different prices, rules, evidence, and risks. Any page that mixes them into one “cheapest GLP-1” list without labels is going to confuse you.

Are there any GLP-1 Black Friday deals for 2026 yet?

No confirmed U.S. telehealth GLP-1 Black Friday offer for 2026 was publicly announced when we checked on August 12, 2026.

That does not mean no sale will appear. It means the honest live tracker starts at zero.

We will not fill an empty 2026 table with year-round intro prices just to make this page look busy. A current promotion belongs in the current-price table. A Black Friday offer belongs here only after it exists.

What would count as a real 2026 deal?

A seasonal offer must beat the provider's own normal price after we include:

• Membership fees
• Medication cost
• Shipping or lab charges
• Cash due today
• Renewal or second-month price
• Dose-based price changes
• Required plan length
• Refund and cancellation terms

A code that changes $149 to $99 for one month and then renews at $299 is not a $99 program. It is a $99 first charge followed by a $299 renewal.

Were last year's Black Friday GLP-1 deals actually good?

Some were. Some were not. Some cannot be scored honestly with the public evidence left online.

The best documented semaglutide number in the two 2025 roundups was OrderlyMeds at $74 a month through a code. Orderly now publishes a $74 effective rate on one current FAQ path, with $149 due for two months, while other official pages show other plan prices. Goby's 2025 discounted bundle was slightly lower than Goby's current starter bundle.

But today's market includes lower provider-stated numbers elsewhere, and some current pricing pages are so inconsistent that a neat winner would be fake precision.

Here is the part that should actually make you angry, and it is the reason we built this page.

The same company. The same weekend. Prices 4.5x apart.

We put the two published 2025 roundups side by side. They covered some of the same companies during the same holiday week.

Same companies. Same holiday weekend. Nobody in the middle checking whether the reader was comparing the same door, plan, dose, or payment schedule.

This does not prove either roundup lied. It proves the number was not portable. One article said its savings appeared when readers clicked through its listing. Coupon path, bundle, dose, and landing page can all change what appears.

So when you see “semaglutide, $74 a month, Black Friday only,” you are not looking at one universal fact about the medicine. You are looking at a fact about one offer path at one moment.

Once you see it, you cannot unsee it.

One company, two official price stories

Online comparisons often collapse Eden's different page structures into one price. We verified two official price stories, and that is enough to show the problem.

One Eden page says compounded semaglutide costs $149 for the first month, then $249 a month. Another Eden page says medication starts at $99, but an active membership is required at $39 for the first month and $99 after that.

That creates two different official stories:

Same company. Different official pages. Different totals.

We are naming that as data, not as a recommendation. We do not link to Eden in a decision CTA on this page.

MEDVi publishes conflicting prices too

MEDVi's own public landing page shows several numbers in one place. It says “start for just $116/mo,” then labels semaglutide $116/mo in one block, while its FAQ says permanent pricing is $166 for semaglutide and $199 for tirzepatide. Another official MEDVi page has published injections starting at $179 and tablets at $249.

FDA also issued MEDVi a warning letter dated February 20, 2026. The letter says FDA viewed specific compounded-drug claims as false or misleading. A warning letter states FDA's concerns and gives the company a chance to respond; it is not a court judgment.

That combination earns one label here: contradictory — unranked.

🎯 If you already know you want the brand name, stop waiting on a rumor

Here is the clean takeaway: there is no verified reason today to expect November 27 to beat the manufacturer programs already live.

What you can do today is learn what you would actually pay. Insurance may beat every cash number on this page.

Ro currently lists Wegovy pill and pen, Zepbound, Foundayo, and Ozempic. Its membership is $39 for the first month, then $149 month to month or an effective $74 a month when a 12-month membership is paid up front. Medication is a separate charge.

Ro says the first $39 membership charge is refunded if you are not eligible for GLP-1 treatment. It also offers a free insurance coverage checker for the Wegovy pen, Zepbound pen, and Ozempic pen. That checker does not request treatment or write a prescription, and it does not currently check coverage for the Wegovy pill, Foundayo pill, or Zepbound KwikPen.

Not sure whether brand-name is your lane? Keep reading. The next section is the reason this page exists.

What actually happened to GLP-1 prices last November?

The most important manufacturer price moves around Black Friday season 2025 were not presented as Black Friday sales.

On November 17, 2025, Novo Nordisk lowered its standard self-pay price for Wegovy and Ozempic from $499 to $349 and started a $199 introductory offer for eligible low-dose fills. Lilly also moved Zepbound direct-pay pricing to $299 at the starting dose and higher tiers above that.

Neither move needed a holiday coupon from a deal roundup.

Sit with that for a second.

A major FDA-approved Wegovy price change happened before Black Friday. It did not need a coupon. It did not need a bundle. It did not depend on which affiliate article you entered through.

Meanwhile, holiday pages were listing compounded-provider codes and could not agree on what the same companies cost.

Why the manufacturer moves mattered more than the holiday label

Three facts were moving at once.

One. Novo said it was bringing lower direct-to-patient prices to consumers months before a 2026 commitment.

Two. Lilly and Novo were both changing direct-pay access in the same market. You did not need a Black Friday label for those changes to matter.

Three. A lower brand-name cash price shrinks the gap between FDA-approved and compounded options. That changes the decision even when no provider runs a seasonal code.

What this means for you: watch manufacturer terms, not just coupon pages. The biggest move may happen before the holiday, after it, or with no holiday name at all.

What we expect for November 2026

We do not know. We are not going to guess.

Here is what we will watch:

• Whether any compounded provider announces a real seasonal offer with a real deadline
• Whether Novo Nordisk or Eli Lilly changes self-pay pricing again
• Whether FDA issues a final decision on the pending 503B bulk-substance proposal
• Whether the programs live today are extended, replaced, narrowed, or ended
• Whether a “monthly” price requires a large payment up front
• Whether existing patients qualify or the offer is new-patient only

We check this page weekly now and daily from November 1 through Cyber Monday. Each live price needs its own verification date.

🎯 Run the Wait-or-Start check right here

Use this four-question check. It works without an email, download, or calculator.

From August 12 to November 27, 107 days pass. That is 15 weeks and two days.

That does not mean everyone should start now. A clinician decides whether treatment is right and when it should begin. It means an unannounced sale is not evidence that waiting is the smarter medical or financial choice.

One GLP-1 offer ends before Black Friday 2026

The limited $149 self-pay offer for eligible Wegovy 4 mg tablet fills ends August 31, 2026. The standard self-pay price is then $199.

That is not a fake countdown. It is a date in the manufacturer's current pricing terms.

We did not find that deadline called out in either 2025 deal roundup. Here is the full decision calendar between today and the end of the year.

Look at the top and bottom rows together:

• The 4 mg tablet offer ends before Black Friday. Waiting for November loses access to that limited $149 offer if the terms do not change.
• The current eligible low-dose pen offer is scheduled to remain live through Black Friday. Waiting until the holiday does not unlock it; it is already here.
• Manufacturer programs can change. Novo says it may modify or cancel the program.

There is no honest version of this math that turns an unannounced holiday offer into a guarantee.

Verify it yourself before paying. Read the pricing footnotes on Wegovy's official cost page. Save the terms and date. A current article can become stale faster than the medicine changes.

🎯 If the Wegovy pill is what you want, the date is real

This is the one place on this page where the word deadline is earned.

The eligible 4 mg $149 offer is scheduled to end August 31, 2026. The 1.5 mg tablet remains listed at $149. Other Wegovy tablet doses have different prices.

Ro lists the Wegovy pill, but its free insurance checker currently covers the Wegovy pen, not the pill. Do not click a coverage checker expecting a pill result it cannot give.

→ See the official Wegovy self-pay terms

What's the cheapest GLP-1 you can get right now, with no coupon?

As of August 12, 2026, manufacturer-confirmed self-pay prices for FDA-approved weight-loss drugs start at $149 for the lowest Wegovy tablet and Foundayo tablet doses. Compounded-provider pages publish lower and higher numbers, but those pages need a second layer of checking because the drugs are not FDA-approved and several providers publish conflicting prices.

This is your baseline. When November comes and somebody advertises “40% off,” compare it to the same lane below.

FDA-approved weight-loss prices today

Ozempic and Mounjaro note: both are FDA-approved for type 2 diabetes, not as weight-loss drugs. Some clinicians may prescribe a drug off-label, but this page does not present diabetes-drug cash prices as interchangeable weight-loss offers.

Membership fees can double the story

With Ro, the first-month membership is $39. The ongoing membership is $149 month to month, or lower as an effective monthly rate when several months are prepaid. Medication is separate.

That means a “$149 medicine” through a service with a $149 monthly membership can mean $298 before other costs, not $149.

The same rule applies anywhere else:

Total first payment = membership + medication + labs + shipping + required prepayment.

If a table does not show that total, it is not yet a usable price comparison.

Compounded prices today: provider-stated, not FDA-approved

Compounded prescriptions are not FDA-approved. These numbers come from providers' public pages. They do not guarantee that a clinician will prescribe, that the product is available in your state, that checkout will match, or that a pharmacy can legally fill the exact prescription for you.

Here is the thing nobody says out loud

The gap between brand-name and compounded has gotten much smaller at the lowest doses.

When a manufacturer-confirmed FDA-approved pill starts at $149 and one compounded provider says $79, the headline gap is $70. That is still real money. But it is not the old comparison between a four-figure list price and a $199 compound.

Now add the facts the headline leaves out:

• The $149 brand price may apply only to a starting or specific dose.
• The compounded price may depend on provider approval and state availability.
• The compounded drug has not gone through FDA premarket review.
• A telehealth membership can add a second charge.
• A lower “monthly” rate may require $750, $1,350, or another large payment now.

If you choose compounded to save money, that is your decision with your clinician. Make it with today's full numbers, not a 2024 price memory.

🎯 If you want the lowest public monthly number and you are comfortable with compounded

Look for a price that does not reset after the first fill. Then verify whether flat means flat at every dose, in every state, through the same pharmacy, and under the same plan.

Embody's homepage lists compounded semaglutide from $79 a month and tirzepatide from $129 a month. Its terms also preserve old, retired intro schedules: semaglutide at $99 followed by $299 and tirzepatide at $149 followed by $399.

That old schedule is the receipt for why the second charge matters.

But the current homepage also says a “Summer Start Promo” is applied. So the clean claim is not “no promo.” The clean claim is: Embody currently publishes a $79 monthly semaglutide starting price and says the dose does not raise the price within the same plan. Verify the final checkout and renewal terms before paying.

Read the honest downside in the next section before you click. There is one, it is real, and for some people it is a dealbreaker.

Why does a "$99 deal" turn into $299?

A GLP-1 intro price can end because the first month ends, because the starting dose ends, or because both end together. If the second charge is not shown beside the first one, the advertised price is incomplete.

This is the mechanism. Once you see it, every deal page reads differently.

The dose trap, in plain words

Many FDA-approved GLP-1 plans use titration. You start at a lower dose and may step up over time under a clinician's direction.

Now look at how several intro programs are written:

• The current $199 Wegovy pen offer applies to eligible new-patient fills at 0.25 mg and 0.5 mg.
• The offer covers the first two eligible fills.
• The standard price after the intro period is higher.

The low dose and low price can end near the same part of treatment. Whether anyone designed that feeling or not, the effect on your wallet is the same.

Build your second-charge line before you enroll

Fill this out from the provider's own checkout and terms:

Screenshot it. Not for us. For you.

Four more things that make the sticker price wrong

1. The price may cover only membership.
“$39 first month” can mean $39 for access to the program, with medication billed separately.

2. Some programs define a month as 28 days.
A 28-day cycle creates about 13 cycles in 364 days. A $179 charge every 28 days is $2,327 across 13 charges, not $2,148 across 12 calendar months.

3. “Starting at” can mean one dose, one plan length, one patient type, or one checkout path.
Ask what the same product costs at the dose your clinician may use later.

4. The lowest monthly number may require the biggest payment today.
“$125 a month” on Yucca's six-month plan means $750 due. “$225 a month” means $1,350 due. Those are real effective monthly rates, but they are not monthly cash flow.

🎯 Straight talk about Embody, since we named its low price

We are not going to show you $79 and hide the catch.

Embody's terms say the initial charge is processed when you purchase the plan, before the clinical review is complete. Its terms say consultation fees are not refundable and discuss a refund for medication not dispensed when a patient is medically ineligible. Its separate refund page says a patient disqualified by the provider receives a full refund.

Those are not the same promise. Get the answer in writing for your exact plan before paying.

There is a bigger terms problem.

Embody publishes three different cancellation cutoffs

Three official pages. Three cutoffs.

That is not a tiny typo in a category built on auto-renewal.

If unclear cancellation rules are a dealbreaker, Embody is not your answer until support gives you one written cutoff that applies to your account.

Here is the honest tradeoff. Embody publishes one of the lowest monthly starting numbers we found, and it says the dose does not raise the price under the same plan. It also charges at checkout and publishes conflicting cancellation and refund language.

For some people the price wins. For some people the terms lose.

If you need the provider decision before the charge:

If you want FDA-approved options and a refundable first Ro membership charge when you are not eligible:

Should you prepay 6 or 12 months to lock in a Black Friday price?

A prepaid plan can lower the effective monthly price. It can also put hundreds or thousands of dollars at risk before you know whether you tolerate treatment, keep using the service, or agree with the renewal and refund rules.

Several 2025 offers and many current low advertised rates require three, six, or twelve months up front.

There is also a live federal rulemaking issue. On April 30, 2026, FDA proposed not to place semaglutide, tirzepatide, and liraglutide on the 503B Bulks List. The original comment deadline was June 30. FDA extended it to July 30, 2026. We found no final determination as of August 12.

Translation: a 12-month prepayment to a compounded seller can outlast the rules, pharmacy relationship, your tolerance, or the provider's current business terms.

What the FDA has actually done, with dates

Two definitions first:

503A pharmacy: generally compounds a prescription for an identified individual patient and must meet section 503A conditions.

503B outsourcing facility: may compound larger batches under section 503B conditions. When using a bulk drug substance, it generally needs the substance on the 503B Bulks List or the compounded drug on FDA's shortage list, among other requirements.

Here is the timeline:

• December 19, 2024 — FDA reaffirmed that the tirzepatide injection shortage was resolved.
• February 21, 2025 — FDA determined that the semaglutide injection shortage was resolved.
• Spring 2025 — FDA's announced enforcement-discretion windows tied to the shortage resolution ended.
• February 6, 2026 — FDA said it intended to take action against non-FDA-approved GLP-1 drugs and misleading marketing.
• March 3, 2026 — FDA announced 30 warning letters to telehealth companies over allegedly false or misleading compounded GLP-1 claims.
• April 1, 2026 — FDA clarified that compounders still must meet the conditions of sections 503A or 503B.
• April 30, 2026 — FDA announced the proposal not to include semaglutide, tirzepatide, and liraglutide on the 503B Bulks List.
• May 1, 2026 — The proposal was published in the Federal Register.
• June 26, 2026 — FDA extended the comment period.
• July 30, 2026 — The extended comment period closed.
• August 12, 2026 — We found no final Federal Register determination.

What is still possible under 503A?

The broad shortage-based path for making copies ended after FDA's shortage decisions and enforcement windows.

A 503A pharmacy may still compound for an identified patient when the prescription and product meet the legal conditions, including limits on regularly making products that are essentially copies of commercially available drugs.

That is not a blanket permission for any website to sell “generic Wegovy” because it costs less. It is a patient-specific compounding pathway with conditions.

The April 30 proposal is about the 503B Bulks List. It is not a final nationwide ban on every patient-specific 503A prescription. Any page that says “FDA banned all compounded GLP-1s” is skipping the hard part.

What happens to your money if the provider has to stop or you need to stop?

Ask these questions before you prepay:

1. What is the written refund rule for unused months? Get the exact section, not a chat promise.
2. When does the charge appear, and what dispute rights does my card issuer give me? Ask your issuer before the charge, because rights and deadlines vary.
3. What happens if a clinician tells me to stop? Side effects, pregnancy, surgery, a new diagnosis, or another medicine can change the plan.
4. What happens if the pharmacy changes? Get the named dispensing pharmacy when available.
5. What happens if the law or provider's program changes? Ask whether unused prepaid months are refunded.
6. Does the price hold if my dose changes? Get the answer in writing.

When prepaying can make sense

We are not against it.

A longer plan can be reasonable when:

• You have read the refund and cancellation terms.
• You know the full amount due today.
• You have already used the treatment long enough to understand your own tolerance, under clinical care.
• The provider names the pharmacy or explains when it will be assigned.
• The price stays clear across doses and renewals.
• Losing access to the unused balance would not wreck your budget.

The bad version is prepaying twelve months to a company you met through a holiday code yesterday, with terms you did not save, in a category under active rulemaking and enforcement.

🎯 If you would rather not bet a year on unfinished rules or unclear terms

Month to month can cost more per month. It costs less to walk away from.

Compare the true monthly choice:

Are compounded GLP-1 Black Friday deals safe and legal?

A discount does not decide whether a compounded prescription is lawful or safe for you. Compounded drugs are not FDA-approved. They do not go through FDA premarket review for safety, effectiveness, or quality. A patient-specific compounded prescription may still be available when the prescription, pharmacy, and product meet applicable federal and state rules.

The marketing deserves its own warning.

FDA announced 30 warning letters on March 3, 2026. FDA then said it issued 25 more in June. That is 55 telehealth warning letters in two waves over compounded GLP-1 marketing.

Warning letters state FDA's concerns and give recipients a chance to respond. They are serious regulatory actions, but they are not court judgments.

55 warning letters in two 2026 waves

Now connect that to this page. The 2025 seasonal offers in the two roundups were concentrated in compounded telehealth programs. That means a 2026 holiday shopper is likely to read marketing from the exact category under active FDA scrutiny.

That does not mean every compounded provider is bad. It does not mean all compounding is illegal. It means the ad itself deserves proof.

The FDA's red-flag list, turned into your checklist

These are based on claims FDA has cited or warned against.

🚩 “Generic Wegovy” or “generic Zepbound.”
An FDA-approved generic has gone through an approval process. A compounded drug is not an FDA-approved generic.

🚩 “The exact same medication.”
FDA has warned against claims that blur compounded products with approved drugs.

🚩 “Same active ingredient” used to imply equal approval, testing, or results.
The approved drug's evidence does not automatically prove the quality or performance of one compounded vial.

🚩 “FDA-approved compounded GLP-1.”
That phrase is wrong. Compounded drugs are not FDA-approved.

🚩 “FDA-approved pharmacy” or “FDA-licensed pharmacy.”
FDA has said federal law does not create those designations for pharmacies or outsourcing facilities.

🚩 The telehealth brand on the vial with no clear compounder.
FDA has cited labeling that can make the telehealth company look like the manufacturer when it is not.

🚩 “Clinically proven” attached to the compounded product without evidence for that exact product.
Trials of Wegovy or Zepbound do not automatically prove a separate compounded product.

🚩 No prescription or no clinician licensed in your state.
A legitimate prescription program needs a real clinical evaluation and lawful pharmacy dispensing.

How to check a provider yourself in about five minutes

1. Find the prescribing clinician's name after assignment. Confirm the license in your state.
2. Find the actual dispensing pharmacy, not just the website brand.
3. Check that pharmacy with your state board of pharmacy.
4. Read the vial or package label when it arrives. Confirm the pharmacy, patient, ingredient, strength, directions, and beyond-use date.
5. Compare the concentration and syringe instructions with what your clinician told you.
6. Contact the provider or pharmacy before using it if anything does not match.
7. Never use a sale as a reason to order more medicine than prescribed.

FDA has received reports of compounded semaglutide dosing errors, including some adverse events that required hospitalization. Confusion between milliliters, milligrams, and “units,” along with different concentrations, can matter.

A discount is not a medical reason to stockpile a prescription drug.

No sales pitch in this section. It is a safety section. The next section shows how to judge the offer itself.

How do you tell a real GLP-1 deal from an ad?

A real deal gives you the normal price, sale price, cash due today, renewal price, exact end date, eligibility, medication lane, and cancellation rule.

If those pieces are missing, you do not have a full price yet. You have an advertisement.

The six questions that reveal the real price

Before you enter a card number:

1. What will I be charged today? Include membership, medication, labs, shipping, and prepaid months.
2. What will I be charged next? Get the number.
3. What exact date will the next charge happen? Get the date.
4. Is the low price tied to a starting dose or a plan length?
5. What is the cancellation cutoff, and which policy controls if two pages disagree?
6. Is the medicine FDA-approved or compounded?

Save the answers.

Your one-page deal-terms checklist

Copy this into your notes:

• Provider:
• FDA-approved or compounded:
• Exact medication and form:
• Dose covered by the price:
• Prescribing fee today:
• Membership today:
• Medication today:
• Other charges today:
• Total due today:
• Next billing date:
• Next total:
• Plan length:
• Refund rule:
• Cancellation cutoff:
• Dispensing pharmacy:
• State availability confirmed:
• Source page saved:
• Date checked:

No email. No download gate. The checklist is right here.

How we label every offer

Two rules:

We will not put a year-round intro price in the 2026 Black Friday table just to make the list look full.

We will not name a “best 2026 Black Friday deal” until at least one seasonal offer passes verification. As of August 12, zero have.

Do this to our links too

Open a private browser window. Go to the provider's own pricing and terms pages. Compare the number you see with the number here.

Affiliate links can lead to a different landing page. That can be legitimate. It can also change the price or bundle. The point is to know which offer you are actually taking.

If our number is wrong, the page needs to change. That is not a polite sentence at the end of a price article. It is the only way the article stays useful.

Should you wait for Black Friday, or start now?

An unannounced sale is not a reason to delay treatment that you and a clinician have decided is right for you. It is also not a reason to rush into treatment.

The decision belongs to your health plan and your real total cost—not to a holiday rumor.

From August 12 to November 27, 107 days pass. That is long enough for prices, eligibility, insurance, your health, and provider terms to change.

Waiting might make sense if

• You have not decided whether you want treatment at all.
• You have not spoken with a clinician.
• You are gathering information and your timing is not medically urgent.
• You want to compare today's saved baseline with a real seasonal offer later.
• You understand that no 2026 seasonal offer is guaranteed.
• The money you may save matters more to you than starting sooner, and your clinician agrees waiting is reasonable.

Waiting probably does not make sense if

• A clinician has told you not to delay.
• You are already in treatment and a gap would disrupt the plan.
• Insurance, Medicare, or a manufacturer program already beats likely cash-sale prices.
• You are waiting only because of a rumor with no official terms.
• You want the eligible Wegovy 4 mg tablet at the limited $149 price before August 31.
• You have a verified current price, can afford it, understand the next charge, and the only thing stopping you is the word “Black Friday.”

Find yourself in this table

Do not stockpile because something is on sale

We will say this plainly because we would rather lose a click than have this go wrong.

A discount is not a reason to buy more prescription medicine than your clinician prescribed.

Not extra vials. Not a twelve-month medicine supply because the rate looks lower. Not a higher dose because it appears to be the same price.

Compounded products have beyond-use dates. Multi-dose vials can create measurement risks. Your treatment can change.

Buy what the prescription and treatment plan call for. That is it.

🎯 You have enough to make the next decision

You have seen six actual 2025 advertised prices. You have seen what the same providers say today where a public comparison is possible. You know which current manufacturer dates matter and which “monthly” rates hide a large payment now.

If your answer is “I want to take the next step,” choose the lane first.

Brand-name, insurance-curious, or looking at an FDA-approved pen:
Check eligible pen coverage with Ro

Lowest public compounded starting number, after reading the terms conflict:
See Embody's current public pricing

Need approval before the card charge:
See Yucca's authorization-hold process

Still not sure which lane is yours:
Take the free 60-second matching path

Is Cyber Monday better than Black Friday for GLP-1 deals?

Cyber Monday 2026 is Monday, November 30, three days after Black Friday. The 2025 roundups did not establish a reliable pattern that Monday produced a lower price. Offers often ran through Monday. That is not the same as getting better on Monday.

Each provider controls its own deadline.

What we will track in 2026

We will label each stage: early access, Black Friday, weekend extension, Cyber Monday, Cyber Week extension, and expired.

If a deadline gets extended, we will log:

• Original deadline
• New deadline
• When the extension appeared
• Whether the price changed
• Whether the company called it an extension

We will not call every extension a “surprise last chance.” Most are just longer sales.

We will not write “only a few spots left” unless the provider publishes a limit that can be checked. No fake countdown timers. A prescription page earns urgency with a real term, not a conversion trick.

How we checked all of this

We compared two published 2025 roundups with current official manufacturer pages, current provider pricing and policy pages, FDA material, the Federal Register, CMS, and FTC guidance.

We logged the access date. We separated direct evidence from secondary evidence. We did not treat an old roundup price as a current provider quote.

What we verified from primary pages on August 11–12, 2026

What came from historical or secondary sources

What remains unresolved

We think publishing the unresolved box is more useful than pretending it is empty.

Where our numbers come from, in order

1. Manufacturer's official program page or terms
2. Provider's official pricing page, terms, and live public checkout path
3. FDA, Federal Register, CMS, FTC, and state boards for regulatory facts
4. Dated reputable reporting for events not fully described on a current official page
5. Historical deal roundups for historical claims only
6. Forums and social posts only to find questions—not to prove a price, medical claim, or legal fact

About the commission

Weight Loss Provider Guide may earn a commission from some providers named on this page.

It does not change your price. It did not change a table number. When two options are genuinely equal for the same reader, compensation may affect which one receives an outbound link. It does not decide what a medicine costs, what FDA said, whether a provider gets marked contradictory, or whether we publish a damaging term.

Examples:

• MEDVi appears in the data with its price conflict and FDA warning letter. It does not receive a recommendation CTA here.
• Eden appears as a worked example of two official price structures. It does not receive a decision CTA.
• Embody receives a CTA only beside the three-way cancellation conflict, payment timing, and refund conflict—not above them.

FTC guidance calls for material connections to be clear and conspicuous. That is why the disclosure appears before the first recommendation, not behind a separate disclosure link.

How we use customer reviews

No customer quote appears on this page unless its exact wording, date, reviewer display name, platform, and invitation status are verified on the publication date.

Customer reviews can help show what enrollment, billing, shipping, support, and cancellation feel like. They cannot prove that a medicine is safe, effective, or right for you. We will not use one person's weight-loss result as clinical evidence.

When reviews are added later, each quote should have:

• Exact wording
• Reviewer name as displayed
• Date
• Platform
• Whether the review was invited
• A note that one experience is not a typical-result claim

An expert making the same pricing point

In November 2025, Vanderbilt University Medical Center health-policy professor Stacie Dusetzina warned that a $199 teaser rate could pull people in, then a jump to $349 could push some off treatment before they saw much benefit.

That is an independent expert describing the same second-charge risk this page shows—even for an FDA-approved option we may recommend.

GLP-1 Black Friday deals: quick answers

When is Black Friday 2026?
Friday, November 27, 2026. Cyber Monday is Monday, November 30, 2026.

Are there any 2026 GLP-1 Black Friday deals yet?
No confirmed U.S. telehealth seasonal offer was found as of August 12, 2026. The live tracker starts at zero.

Were 2025 GLP-1 Black Friday deals actually cheaper?
Orderly's reported $74 rate is matched by one current Orderly effective rate, although today's plan requires $149 for two months and other official Orderly pages show other prices. Goby's reported $93 rate is below its current $99 effective starter rate. Other old offers are beaten by today's market, and some cannot be scored because current pages conflict or no matching public plan is available.

Do Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo go on sale for Black Friday?
Neither 2025 roundup listed a manufacturer Black Friday offer for those drugs, and no 2026 manufacturer Black Friday offer was announced when checked. Manufacturer self-pay programs can still change outside the holiday.

Does the Wegovy pill price change before Black Friday?
The limited $149 offer for eligible 4 mg tablet fills ends August 31, 2026. The standard 4 mg self-pay price is $199 after that. The 1.5 mg tablet remains listed at $149 under current terms.

Is the $199 Wegovy pen price a Black Friday deal?
No. It is a current manufacturer introductory offer for the first two eligible new-patient fills of 0.25 mg and 0.5 mg, scheduled through December 31, 2026.

Is Zepbound really $299 a month?
The current self-pay program lists $299 for 2.5 mg, which is a starting dose and not a maintenance dose. It lists $399 for 5 mg and $449 for higher doses under current terms. The $449 higher-dose price requires refilling within 45 days, and a month is defined as 28 days.

Is Foundayo really $149 a month?
The regular self-pay price is $149 at 0.8 mg. Higher regular tiers are $199, $299, or $349. Current terms list a $299 purchase offer for eligible 14.5 mg and 17.2 mg fills when the refill timing rule is met. Always compare the dose and terms you may actually use.

Are GLP-1 Black Friday promo codes legitimate?
A code can be real and still create a misleading headline. Check the full first payment, second payment, plan length, dose, eligibility, and renewal price.

Does the advertised price include medication?
Sometimes. Sometimes it is membership only. Ro's membership and medicine are separate charges. Add every required charge before comparing.

Are compounded GLP-1 medications FDA-approved?
No. Compounded drugs are not FDA-approved and are not FDA-approved generic versions of Wegovy or Zepbound.

Can compounded semaglutide or tirzepatide still be legal?
Patient-specific compounding may still occur when the prescription, product, pharmacy, and facts meet the conditions of federal and state law. The shortage-based path for broad copies ended. The pending 503B Bulks List proposal is not a final blanket ban on every 503A patient-specific prescription.

Is a prescription required?
A lawful prescription program includes clinical evaluation and dispensing through an authorized pharmacy. Walk away from a site selling prescription GLP-1 medicine with no real prescription process.

Can existing patients use a Black Friday code?
Only when the terms say so. Many promotions are limited to new patients or new plans. Do not create a duplicate account or misstate your status.

Will my price rise when my dose rises?
It depends. Manufacturer programs and provider plans can be dose-specific. Embody says its price does not rise with dose under the same plan, but its other terms still need careful review. Get the answer in writing.

Is billing monthly or every 28 days?
Check the definition. Lilly defines a Zepbound self-pay month as 28 days. Other programs may use calendar-month billing or prepaid terms.

Should I prepay twelve months for a bigger discount?
Only after you understand the refund rule, know the full cash due today, can afford to lose access to the balance, and have discussed treatment with a clinician. The FDA 503B proposal was still unresolved when checked.

Can I use an HSA or FSA?
Some providers say yes, but eligibility depends on the exact expense and your plan. Keep an itemized receipt and confirm with the plan administrator.

What if I have Medicare?
Check the Medicare GLP-1 Bridge before using these cash prices. Eligible Medicare Part D beneficiaries can receive certain GLP-1 drugs for weight management with a $50 copay through December 31, 2027. Not everyone qualifies.

Should I wait for Cyber Monday instead?
The 2025 evidence shows offers often ran through Monday. It does not prove Monday was cheaper. Compare the actual total and terms.

Will there be GLP-1 Black Friday deals in 2026?
We do not know. This page will add an offer only after official terms can be checked.

Still not sure which GLP-1 program is right for you? Take the free 60-second matching path.

It sorts by budget, FDA-approved versus compounded, insurance, medicine form, and state. The goal is a lane and a plan before a provider click.

Related guides

• How to get a GLP-1 safely online — clinician, pharmacy, label, and dosing checks
• Best FDA-approved brand-name GLP-1 telehealth providers — stay in the approved-drug lane
• Best GLP-1 pills for weight loss — compare oral options by approval, dose, and price
• Medicare GLP-1 Bridge eligibility and $50 copay — use the current CMS rules if you have Medicare Part D

Sources

1. Wegovy official cost and coverage information, checked August 12, 2026.
2. Foundayo official coverage and savings page, checked August 12, 2026.
3. LillyDirect Zepbound self-pay page, checked August 12, 2026.
4. FDA approval announcement for Foundayo, April 1, 2026.
5. Ro weight-loss pricing, checked August 12, 2026.
6. Ro GLP-1 Insurance Coverage Checker, checked August 12, 2026.
7. Embody homepage, Terms and Conditions, and Cancellation and Refund Policy, checked August 11–12, 2026.
8. Yucca Health how it works and pricing, checked August 12, 2026.
9. OrderlyMeds pricing and OrderlyMeds pricing FAQ, checked August 12, 2026.
10. GobyMeds public pricing, checked August 12, 2026.
11. iVIM compounded GLP-1 pricing, checked August 12, 2026.
12. Fridays pricing, checked August 12, 2026.
13. SHED weight-loss products, checked August 12, 2026.
14. MEDVi price-lock landing page and MEDVi $179/$249 landing page, checked August 12, 2026.
15. FDA warning letter to MEDVi, February 20, 2026.
16. Eden semaglutide program page and Eden GLP-1 cost page, checked August 12, 2026.
17. The GLP-1 Effect, “I Gathered All the GLP-1 Black Friday Deals”, November 26, 2025.
18. GLP Winner, “Black Friday GLP-1 Telehealth Deals Guide”, November 24, 2025.
19. Novo Nordisk November 17, 2025 self-pay announcement.
20. Lilly Zepbound direct-price announcement, checked for historical pricing context.
21. FDA proposal on semaglutide, tirzepatide, and liraglutide for the 503B Bulks List, May 1, 2026.
22. Federal Register comment-period extension to July 30, 2026, June 26, 2026.
23. FDA compounding-policy clarification, updated April 1, 2026.
24. FDA announcement of 30 telehealth warning letters, March 3, 2026.
25. FDA guidance for telehealth companies promoting compounded drugs, June 2026.
26. Reuters report on FDA's June wave of 25 warning letters, June 16, 2026.
27. FDA compounded semaglutide dosing-error alert, July 26, 2024.
28. CMS Medicare GLP-1 Bridge, checked August 12, 2026.
29. FTC Endorsement Guides Q&A, checked August 12, 2026.
30. Drugs.com/HealthDay report quoting Stacie Dusetzina, November 19, 2025.

Last verified: August 12, 2026. Next scheduled check: September 1, 2026.